Importance of Substrate Composition, pH and Other Variables on Tissue Factor Enhancement of Factor Vlla Activity

 

PDF Download Buy Article Permissions and Reprints

Summary

Tissue factor (TF) markedly enhances the ability of factor VIIa (FVIIa) to cleave both macromolecular and small peptidyl substrates. Using soluble mutant TF (sTF) to investigate TF-enhanced FVIIa amidolytic activity in solution, we screened thirty-four commercially available peptidyl-p-nitroanilide substrates and found that substrate hydrolysis rates were influenced by both the peptide sequence and the N-terminal blocking group (MeSO₂ > MeO-CO or free N-terminus >> benzoyl). Two substrates (Chromozym t-PA: MeSO₂-D-Phe-Gly-Arg-pNA; and CBS 34.47: H-D-cyclohexylglycyl-α-aminobutyryl-Arg-pNA) were cleaved at rates higher than those of previously reported chromogenic substrates for FVIIa. The pH range of FVIIa amidolytic activity toward Chromozym t-PA was 6.5 to 10 with an optimum at pH 7.8, while sTF·VIIa had a higher pH optimum (pH 8.4 to 8.5). The degree of enhancement of FVIIa activity by sTF varied from 12-fold at pH 7.5 to 73-fold at pH 9.9. The effect of a variety of agents on FVIIa amidolytic activity was surveyed: most decreased activity, while glycerol and ethylene glycol enhanced the activity of FVIIa but not sTF·VIIa. These results indicate that the effect of sTF on the catalytic center of FVIIa is pH-dependent, and that certain polyalcohols can partially substitute for TF.

• References

• 1 Carson SD, Brozna JP. The role of tissue factor in the production of thrombin. Blood Coag Fibrinol 1993; 4: 281-292
  CrossrefPubMedGoogle Scholar
• 2 Pedersen AH, Lund-Hansen T, Bisgaard-Frantzen H, Olsen F, Petersen LC. Autoactivation of human recombinant coagulation factor VII. Biochemistry 1989; 28: 9331-9336
  CrossrefPubMedGoogle Scholar
• 3 Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30: 10819-10824
  CrossrefPubMedGoogle Scholar
• 4 Mann KG, Jenny RJ, Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Ann Rev Biochem 1988; 57: 915-956
  CrossrefPubMedGoogle Scholar
• 5 Waxman E, Laws WR, Laue TM, Nemerson Y, Ross JBA. Human factor VIla and its complex with soluble tissue factor: Evaluation of assymetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. Biochemistry 1993; 32: 3005-3012
  CrossrefPubMedGoogle Scholar
• 6 Rezaie AR, Fiore MM, Neuenschwander PF, Esmon CT, Morrissey JH. Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody. Prot Express Purif 1992; 3: 453-460
  CrossrefPubMedGoogle Scholar
• 7 Shigematsu Y, Miyata T, Higashi S, Miki T, Sadler JE, Iwanaga S. Expression of human soluble tissue factor in Yeast and enzymatic properties of its complex with factor VIla. J Biol Chem 1992; 267: 21329-21337
  PubMedGoogle Scholar
• 8 Ruf W, Rehemtulla A, Morrissey JH, Edgington TS. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 1991; 266: 2158-2166 (correction in J Biol Chem 1991 266 16256)
  PubMedGoogle Scholar
• 9 Higashi S, Nishimura H, Fujii S, Takada K, Iwanaga S. Tissue factor potentiates the factor Vila-catalyzed hydrolysis of an ester substrate. J Biol Chem 1992; 267: 17990-17996
  PubMedGoogle Scholar
• 10 Lawson JH, Butenas S, Mann KG. The evaluation of complex-dependent alterations in human factor VIla. J Biol Chem 1992; 267: 4834-4843
  PubMedGoogle Scholar
• 11 Pedersen AH, Nordfang O, Norris F, Wiberg FC, Christensen PM, Moeller KB, Meidahl-Pedersen J, Beck TC, Norris K, Hedner U, Kisiel W. Recombinant human extrinsic pathway inhibitor. J Biol Chem 1990; 265: 16786-16793
  PubMedGoogle Scholar
• 12 Kam C-M, Vlasuk GP, Smith DE, Arcuri KE, Powers JC. Thioester chromogenic substrates for human factor Vila: Substituted isocoumarins are inhibitors of factor VIla and in vitro anticoagulants. Thromb Haemost 1990; 64: 133-137
  Article in Thieme ConnectPubMedGoogle Scholar
• 13 Krishnaswamy S. The interaction of human factor VIla with tissue factor. J Biol Chem 1992; 267: 23696-23706
  PubMedGoogle Scholar
• 14 Morrissey JH, Fakhrai H, Edgington TS. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 1987; 50: 129-135
  CrossrefPubMedGoogle Scholar
• 15 Neuenschwander PF, Morrissey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. J Biol Chem 1992; 267: 14477-14482
  PubMedGoogle Scholar
• 16 Jesty J, Nemerson Y. The activation of bovine coagulation factor X. In: Methods in Enzymology Vol. 45. Lorand L. (ed). New York: Academic Press; 1976. pp 095-107
  Google Scholar
• 17 Smith RL. Titration of activated bovine factor X. J Biol Chem 1973; 248: 2418-2423
  PubMedGoogle Scholar
• 18 Bevington PR. Data Reduction and Error Analysis for the Physical Sciences. New York: McGraw-Hill 1969; pp 204-246
  PubMedGoogle Scholar
• 19 Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. J Soc Industr Appl Math 1963; 11: 431-441
  CrossrefPubMedGoogle Scholar
• 20 Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci 1986; 83: 2412-2416
  CrossrefPubMedGoogle Scholar
• 21 Takeya H, Kawabata SI, Nakagawa K, Yamamichi Y, Miyata T, Iwanaga S, Takao T, Shimonishi Y. Bovine factor VII. Its purification and complete amino acid sequence. J Biol Chem 1988; 263: 14868-14877
  PubMedGoogle Scholar
• 22 Brothers AB, Clarke BJ, Sheffield WP, Blajchman MA. Complete nucleotide sequence of the cDNA encoding rabbit coagulation factor VII. Thromb Res 1993; 69: 231-238
  CrossrefPubMedGoogle Scholar
• 23 Leytus SP, Chung DW, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor X. Proc Natl Acad Sci 1984; 81: 3699-3702
  CrossrefPubMedGoogle Scholar
• 24 Fung MR, Campbell RM, MacGillivray RTA. Blood coagulation factor X mRNA encodes a single polypeptide chain containing a prepro leader sequence. Nucleic Acids Res 1984; 12: 4481-4492
  CrossrefPubMedGoogle Scholar
• 25 Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci 1982; 79: 6461-6464
  CrossrefPubMedGoogle Scholar
• 26 Katayama K, Ericsson LH, Enfield DL, Walsh KA, Neurath H, Davie EW, Titani K. Comparison of the amino acid sequence of bovine coagulation factor IX (Christmas factor) with other vitamin K-dependent plasma proteins. Proc Natl Acad Sci 1979; 76: 4990-4994
  CrossrefPubMedGoogle Scholar
• 27 Sarkar G, Koeberl DD, Sommer SS. Direct sequencing of the activation peptide and the catalytic domain of the factor IX gene in six species. Genomics 1990; 6: 133-143
  CrossrefPubMedGoogle Scholar
• 28 Evans JP, Watzke HH, Ware JL, Stafford DW, High KA. Molecular cloning of a cDNA encoding canine factor IX. Blood 1989; 74: 207-212
  PubMedGoogle Scholar
• 29 Wu SM, Stafford DW, Ware J. Deduced amino acid sequence of mouse coagulation factor IX. Gene 1990; 86: 275-278
  CrossrefPubMedGoogle Scholar
• 30 Lottenberg R, Hall JA, Pautler E, Zupan A, Christensen U, Jackson CM. The action of factor Xa on peptide p-nitroanilide substrates: substrate selectivity and examination of hydrolysis with different reaction conditions. Biochem Biophys Acta 1986; 874: 326-336
  CrossrefPubMedGoogle Scholar
• 31 Le BonniecBF, MacGillivray RTA, Esmon CT. Thrombin Glu-39 restricts the P’3 specificity to nonacidic residues. J Biol Chem 1991; 266: 13796-13803
  PubMedGoogle Scholar